Racial/Ethnic Issues in Evaluation, Risk Decisions, and Treatment of ASCVD Risk Racial/Ethnic Groupings Asian * Hispanic/Latino Blacks/African Comments Evaluation ASCVD issues informed by race/ethnicity ASCVD issues informed by race/ ethnicity ASCVD risk in people of South Asian and East Asian origin varies by country of origin; individuals from South Asia (see below) have increased ASCVD risk. Race/ethnicity and country of origin, together with socioeconomic status and acculturation level, may explain risk factor burden more precisely (eg, ASCVD risk is higher among individuals from Puerto Rico than those from Mexico). ASCVD risk assessment in black women shows increased ASCVD risk compared with their otherwise similar white counterparts There is heterogeneity in risk according to racial/ethnic group and within racial/ethnic groups. Native American/ Alaskan populations have high rates of risk factors for ASCVD compared with non-Hispanic Lipid issues informed by Asian Americans have lower levels of HDL-C than whites. Hispanic/Latino women have higher prevalence of low HDL-C compared to Hispanic/ Latino men. Blacks have higher levels of HDL-C and lower levels of triglycerides than non-Hispanic whites or Mexican Americans. All ethnic groups appear to be at greater risk for dyslipidemia, but important to identify those with more sedentary behavior and less favorable diet. There is higher prevalence of LDL-C among Asian Indians, Filipinos, Japanese, and Vietnamese than among whites. An increased prevalence of high TG was seen in all Asian American subgroups. Metabolic issues informed by race/ Increased MetS is seen with lower waist circumference than in whites. DM is disproportionately present compared with whites and blacks. There is increased prevalence of MetS and DM in Mexican Americans compared with whites and Puerto Ricans. There is increased DM and hypertension. There is increased prevalence of DM. Features of MetS vary by race/ethnicity. 